Answers are grounded in this paper and cite their sources.
This case report explores a rare occurrence of Idiopathic Intracranial Hypertension (IIH) in conjunction with COVID-19 infection, a scenario that has received minimal attention in the literature to date. A 49-year-old female with no significant medical history presented with rapidly progressing bilateral vision loss and was found to have grade 3 bilateral optic disc edema alongside a positive COVID-19 diagnosis. Despite the absence of traditional risk factors for IIH, such as obesity or a prior history of similar symptoms, the patient's clinical presentation suggested a possible link between her IIH and COVID-19 infection. Diagnostic workup included normal cerebrospinal fluid analysis and MRI findings, except for an empty sella turcica. The patient underwent successful bilateral endoscopic optic nerve decompression surgery following medical management that included mannitol, dexamethasone, low molecular weight heparin, acetazolamide, vitamin D3 supplementation, ivermectin, and oxygen therapy. Significant symptomatic improvement was observed postoperatively. This case highlights the necessity for heightened awareness among clinicians regarding the potential for COVID-19 to precipitate or exacerbate IIH, underlining the importance of considering IIH in the differential diagnosis of COVID-19 patients presenting with neurological symptoms to prevent irreversible outcomes. Further research is encouraged to investigate the relationship between COVID-19 and IIH, which could offer new insights into their management and preventative strategies.
No takes yet. Share an insight, caveat, or question.
Sood et al. (2024) studied this question.
Synapse has enriched 8 related papers. Consider them for comparative context: